New Study Uncovers Metabolic Vulnerability in High-Risk Myelodysplastic Syndromes
Researchers at the University of Colorado Anschutz Cancer Center have identified a metabolic weakness in the stem cells driving high-risk myelodysplastic syndromes, uncovering an unusual cellular energy dependency that could enable more targeted treatments for the aggressive blood cancer, according to a study published in Blood Cancer Discovery. NAD Dependence in High-Risk MDS Stem Cells … Read more